BOSKABADY M H, SNASHALL P D. ENHANCED HISTAMINE H I RECEPTOR BLOCKADE WITH CHLORPHENIRAMINE IN THE ASTHMATIC TRACHEO-BRONCHIAL TREE: FURTHER EVIDENCE FOR INCREASED DRUG DELIVERY IN ASTHMA. Med J Islam Repub Iran 1997; 11 (2) :115-122
URL:
http://mjiri.iums.ac.ir/article-1-1115-en.html
From the Department of Physiology, Ghaem Medical Center, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract: (4934 Views)
We have measured the competitive antagonistic effect of chlorpheniramine
in bronchi of 8 normal and 12 asthmatic subjects. Classical pharmacological
theory states that the degree of competitive antagonism depends only upon 1)
antagonist concentration at the receptor, and 2) receptor affinity. Delivery and
affinity also influence agonist responsiveness, but measurement of bronchial
antagonism allows study of these factors in isolation. Bronchial responsiveness to
histamine was measured as the dose required to produce a 35% fall in specific
conductance (sGaw), called PD35• On different days, 2 measurements of control
PD35 were made on each subject. Measurements of PD35 were also repeated after
inhalation of 1.45 mg chlorpheniramine and intravenous injection of 0.17 mg/kg
chlorpheniramine. Antagonist effect of chlorpheniramine was measured as Dose
Ratio-l (DR-I), where DR= PD35 after chlorpheniramine/control PD35• Geometric
mean of DR -1 with inhaled chlorpheniramine in asthmatic subjects (5.8) was 6.8
times that of normal subjects (0.86) (p= 0.002), and DR-l with intravenous
chlorpheniramine in asthmatic subjects (4.4) was 2.75 times that of normal
subjects (1.6) (p=0.005). There were significant negative correlations between
PD35 and DR-I, whether chlorpheniramine was administered by inhalation (r=
-0.87, p